| Host: |
Goat |
| Applications: |
Pep-ELISA/WB/IHC |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Goat polyclonal antibody anti-TPTE/PTEN2 (Internal) is suitable for use in ELISA, Western Blot and Immunohistochemistry research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
| Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Concentration: |
0.5 mg/mL |
| Dilution Range: |
WB-1-3µg/mlIHC-2.5µg/mlELISA-antibody detection limit dilution 1:16000. |
| Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
| Gene Symbol: |
TPTE |
| Gene ID: |
7179 |
| Uniprot ID: |
TPTE_HUMAN |
| Immunogen Region: |
Internal |
| Accession Number: |
NP_954870.2; NP_954868.1; NP_954869.1 |
| Specificity: |
This antibody is expected to recognise all reported isoforms (NP_954870.2, NP_954868.1 and NP_954869.1). It may cross-react with the almost identical TPTE2 (GeneID 93492; NP_570141.2, NP_954864.1, NP_954863.1). |
| Immunogen Sequence: |
ERRTDKTHSEKFQ |
| Function | Could be involved in signal transduction. |
| Protein Name | Putative Tyrosine-Protein Phosphatase TpteCancer/Testis Antigen 44Ct44Transmembrane Phosphatase With Tensin HomologyTumor Antigen Bj-Hcc-5 |
| Database Links | Reactome: R-HSA-1660514 |
| Cellular Localisation | MembraneMulti-Pass Membrane Protein |
| Alternative Antibody Names | Anti-Putative Tyrosine-Protein Phosphatase Tpte antibodyAnti-Cancer/Testis Antigen 44 antibodyAnti-Ct44 antibodyAnti-Transmembrane Phosphatase With Tensin Homology antibodyAnti-Tumor Antigen Bj-Hcc-5 antibodyAnti-TPTE antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
